Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvectis Pharma, Inc.

8.76
-0.2000-2.23%
Post-market: 8.24-0.5167-5.90%16:27 EDT
Volume:140.71K
Turnover:1.22M
Market Cap:204.91M
PE:-7.89
High:9.40
Open:9.02
Low:8.10
Close:8.96
Loading ...

Nuvectis Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
26 Feb

Optimistic Buy Rating for Nuvectis Pharma Driven by Promising Oncology Pipeline and Strong Financial Position

TIPRANKS
·
26 Feb

Nuvectis Pharma price target lowered to $11 from $21 at H.C. Wainwright

TIPRANKS
·
26 Feb

Nuvectis Pharma, Inc. : H.c. Wainwright Cuts Target Price to $11 From $21

THOMSON REUTERS
·
26 Feb

Nuvectis Pharma 2024 Net Loss $19M

Benzinga
·
25 Feb

Nuvectis Pharma reports FY24 EPS ($1.11) vs. ($1.43) last year

TIPRANKS
·
25 Feb

Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights

GlobeNewswire
·
25 Feb

Major Investment Alert: Shareholder’s Big Move in Nuvectis Pharma!

TIPRANKS
·
12 Feb

Nuvectis Pharma Closes Stock Offering, Says Underwriter Exercised Overallotment Option

MT Newswires Live
·
07 Feb

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option

THOMSON REUTERS
·
07 Feb

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option

GlobeNewswire
·
07 Feb

Nuvectis Pharma Prices $13.5 Million Public Offering of Shares

MT Newswires Live
·
05 Feb

Nuvectis Pharma 2.7M share Spot Secondary priced at $5.00

TIPRANKS
·
05 Feb

Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock

THOMSON REUTERS
·
05 Feb

Nuvectis Pharma Inc - Prices Public Offering of 2.7 Mln Shares at $5.00/Share

THOMSON REUTERS
·
05 Feb

Nuvectis Pharma Inc: Commenced an Underwritten Public Offering of Its Common Stock

THOMSON REUTERS
·
05 Feb

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
05 Feb

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
05 Feb

Insiders hold 63% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently

Simply Wall St.
·
04 Jan

Great week for Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders who have 63% stake and they haven’t stopped buying

Simply Wall St.
·
29 Dec 2024